NCT07628985 clinical trial report covering Bofanglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262117 clinical trial report covering JYP-0061, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262175 clinical trial report covering NHL35700, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07633236 clinical trial report covering Olanzapine, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07633873 clinical trial report covering Enlonstobart, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07632690 clinical trial report covering MHB088C, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07633119 clinical trial report covering SNA02-48, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07634367 clinical trial report covering HSK-39004, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07631364 clinical trial report covering Disodium edetate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07632157 clinical trial report covering Magnesium Carbonate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07632898 clinical trial report covering IkT-001Pro, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262234 clinical trial report covering Relugolix, Phase 3, endpoints, sponsor, geography, readout timing and development white space.